Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4465842 | 0.85 | USP2 (0.48) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL4465846 | 0.85 | USP2 (0.48) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL6118063 | 0.85 | USP2 (0.48) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL13030012 | 0.84 | FAAH (0.50) | USP2LMNAALOX15 | |
| SCHEMBL16350138 | 0.84 | FAAH (0.50) | USP2LMNAALOX15 | |
| SCHEMBL16416073 | 0.82 | USP2 (0.48) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL17784472 | 0.82 | USP2 (0.48) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL4361309 | 0.81 | USP2 (0.40) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL4361313 | 0.81 | USP2 (0.40) | ALDH1A1KDM4EUSP2LMNAMMP9 | |
| SCHEMBL9675619 | 0.81 | USP2 (0.40) | ALDH1A1KDM4EUSP2LMNAMMP9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1121345-A1 | ESTERS OF (+)-ALPHA-( 2,3- DIMETHOXYPHENYL) -1- 2-(4- FLUOROPHENYL) ETHYL]-4- PIPERIDINEMETHANOL AND THEIR USE AS PRODRUGS OF THE 5HT2A RECEPTOR ANTAGONIST MDL 110,907 | Aventis Pharmaceuticals Inc. (US) | 2001-08-08 | — | — | EP | disclosed |
| US-6063793-A | ANTISEROTONIN AGENTS, PSYCHOLOGICAL DISORDERS AND TREATMENT OF SCHIZOPHRENIA | HOECHST MARION ROUSSEL, INC. (US) | 2000-05-16 | — | — | US | disclosed |
| WO-2000021930-A1 | ESTERS OF (+)-ALPHA-( 2,3- DIMETHOXYPHENYL) -1-[2-(4- FLUOROPHENYL) ETHYL]-4- PIPERIDINEMETHANOL AND THEIR USE AS PRODRUGS OF THE 5HT2A RECEPTOR ANTAGONIST MDL 110,907 | AVENTIS PHARMACEUTICALS INC. (US) | 2000-04-20 | — | — | WO | disclosed |
| US-6028083-A | ANTAGONIZE EFFECTS OF SEROTONIN AT THE 5HT.SUB.2A RECEPTOR AND ARE USEFUL IN TREATING VARIOUS CONDITIONS SUCH AS, PSYCHOSES SUCH AS SCHIZOPHRENIA | HOECHST MARION ROUSSEL, INC. (US) | 2000-02-22 | — | — | US | disclosed |
| EP-0662834-A4 | NOVEL EPOXIDE-CONTAINING COMPOUNDS. | CELL THERAPEUTICS INC (US) | 1996-04-17 | — | — | EP | disclosed |
| EP-0662834-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1995-07-19 | — | — | EP | disclosed |
| WO-1994006431-A1 | NOVEL EPOXIDE-CONTAINING COMPOUNDS | CELL THERAPEUTICS, INC. (US) | 1994-03-31 | — | — | WO | disclosed |
| US-4526900-A | 7-Oxabicycloheptane substituted oxa prostaglandin analogs and their use in the treatment of thrombolytic disease | E. R. SQUIBB & SONS, INC. (US) | 1985-07-02 | — | — | US | disclosed |